AstraZeneca, Daiichi Sankyo’s drug shows promise in breast cancer patients in trial
Roland Magnusson AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) said on Thursday that their medicine datopotamab deruxtecan (Dato-DXd) showed durable ...
